1. Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple‐dose study. Issue 7 (24th March 2022) Authors: Kubitza, Dagmar; Heckmann, Michael; Distler, Jana; Koechel, Annemone; Schwers, Stephan; Kanefendt, Friederike Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 7(2022) Page Start: 3447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗